We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current KRRO market cap is 320.9M. The company's latest EPS is USD -8.7293 and P/E is -4.10.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.8M | -12.67M | -41.23M | -21.45M | -24.13M |
| Net Income | -10.8M | -11.61M | -39.22M | -19.56M | -21.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.95M | 36.98M | 14.07M | 0 | 0 |
| Operating Income | -20.68M | -27.55M | -84.03M | -83M | -84.53M |
| Net Income | -19.8M | -26.51M | -84.69M | -81.58M | -81.17M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 79.38M | 46.35M | 221.66M | 197.99M | 249.59M |
| Total Liabilities | 33.98M | 9.61M | 51.75M | 46.63M | 51.51M |
| Total Equity | 45.41M | 36.74M | 169.91M | 151.36M | 198.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.22M | 264.72M | 185.36M | 121.24M | 221.66M |
| Total Liabilities | 55.86M | 72.23M | 54.53M | 52.04M | 51.75M |
| Total Equity | 167.36M | 192.49M | 130.82M | 69.2M | 169.91M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.56M | -27.36M | -67.28M | -21.89M | -36.48M |
| Investing | 24.71M | 31.53M | 11.16M | -5.61M | -108M |
| Financing | -14.14M | -14.13M | 187.76M | 139k | 67.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 34.22M | -45.19M | -76.06M | -58.24M | -67.28M |
| Investing | -18.26M | 10.4M | -66.13M | 31.13M | 11.16M |
| Financing | 142.02M | 56.69M | 1.36M | -577k | 187.76M |
| Market Cap | 320.9M |
| Price to Earnings Ratio | -4.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2 |
| Price to Book Ratio | 1.96 |
| Dividend Yield | - |
| Shares Outstanding | 9.3M |
| Average Volume (1 week) | 73.67k |
| Average Volume (1 Month) | 68.32k |
| 52 Week Change | 165.46% |
| 52 Week High | 97.91 |
| 52 Week Low | 13.00 |
| Spread (Intraday) | 1.18 (3.35%) |
| Company Name | Korro Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.korrobio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
